Joseph Driscoll - 22 Dec 2022 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Reporting relationship
Chief Financial Officer
Issuer ticker
AKYA
Reported as of
22 Dec 2022
Net transaction value
+$110,000
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
27 Dec 2022, 15:05:02 UTC
Prior SEC filing
16 Dec 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Joseph Driscoll, by Brian McKelligon, as Attorney-in-Fact

Key filing fact

Joseph Driscoll filed Form 4 for Akoya Biosciences, Inc. (AKYA) on 27 Dec 2022.

Key facts

  • This page summarizes Joseph Driscoll's Form 4 filing for Akoya Biosciences, Inc. (AKYA).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 27 Dec 2022, 15:05.

Change

  • Previous filing in this sequence was filed on 16 Dec 2022.
  • Current net transaction value: +$110,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AKYA transaction

Common Stock

Options Exercise

Transaction value
$110,000
Shares
+250,000
Change %
+2000%
Price
$0.4400*
Shares after
262,500
Date
22 Dec 2022
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AKYA transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-250,000
Change %
-69%
Price
$0.000000
Shares after
110,958
Date
22 Dec 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
250,000
Exercise price
$0.4400
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option will be fully vested on 03/18/2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .